In the in vivo experiments, blocking of the Tim-3 pathway resulted in increased CD36 and HO-1 expression in macrophages and decreased L. monocytogenes infection, thus identifying a new mechanism by which Tim-3 induces infection tolerance. The gene discussed is HAVCR2; the disease is infection.